Skip to content

Interstitial Lung Diseases in the Veterans Administration

Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02479126
Enrollment
3000
Registered
2015-06-24
Start date
2016-07-31
Completion date
2023-06-30
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Keywords

Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Electronic Health Records, Computed Tomography, Mortality, Hospitalization, Acute care visits, Anti-inflammatory drug therapies

Brief summary

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

Interventions

None listed

Sponsors

Durham VA Medical Center
CollaboratorFED
Boehringer Ingelheim
CollaboratorINDUSTRY
Robert Tighe
Lead SponsorFED

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3

Exclusion criteria

* Inadequate documentation of patient receiving care for ILD in the health records

Design outcomes

Primary

MeasureTime frame
Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Populationup to 5 years
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Populationup to 5 years

Secondary

MeasureTime frameDescription
Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Diseaseup to five yearsCompare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population
Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Diseaseup to 5 yearsWill compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology
Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary providerup to 5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026